{"cursor":"5079","size":15,"audio":[],"currentlang":"en","article":"In a clinical research trial, a 'clinical endpoint' generally refers to\noccurrence of a disease, symptom, sign or laboratory abnormality that\nconstitutes one of the target outcomes of the trial, but may also refer to any\nsuch disease or sign that strongly motivates the withdrawal of that individual\nor entity from the trial, then often termed humane (clinical) endpoint.\n","linknr":104,"url":"Clinical_endpoint","recorded":1362576145,"links":11,"instances":[],"pdf":[],"categories":["Clinical research"],"headings":["In general sense","Clinical trial endpoints","Humane endpoint","Surrogate endpoint","Combined endpoint","References"],"image":["//bits.wikimedia.org/static-1.21wmf10/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Clinical_trial","Disease","Symptom","Medical_sign","Medication","Myocardial_infarction","Control_group","Statistically_significant","Experimental_animal","Surrogate_endpoint","National_Institutes_of_Health","Myocardial_infarction"]}